Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

BioFocus Launches Four Compound Libraries Targeting Kinases and Protein-Protein Interactions

Published: Tuesday, April 13, 2010
Last Updated: Tuesday, April 13, 2010
Bookmark and Share
These new libraries contain novel, drug-like compounds that specifically target kinases and protein-protein interactions.

BioFocus has announced the launch of four biologically targeted libraries. These new libraries contain novel, drug-like compounds that specifically target kinases and protein-protein interactions.

BioFocus’ three new SoftFocus® kinase libraries (SFK61, SFK62 and SFK63) target either the hinge region, allosteric sites or novel binding modes. The SFK collection has been independently determined to have the greatest population of kinase-like molecules available for screening.

BioFocus’ second Helix Mimetic library (HM02) is based on a novel structure that interacts with protein helices. This library is designed to inhibit protein-protein interactions, but can also target other helical recognition motifs such as the pore region of ion channels.

“2010 marks the 11th year of BioFocus’ commitment to producing leading compound libraries for the discovery sector” said Richard Gordon, Senior Director, Sales and Marketing. “Innovative design and compound novelty ensure we provide our clients with the highest chance of success.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioFocus Extends its Collaboration with The Michael J. Fox Foundation
BioFocus has extended its collaboration agreement for Parkinson’s Research.
Thursday, April 18, 2013
BioFocus Announces Agreement with ChanTest
BioFocus expands ion channel offering.
Thursday, February 07, 2013
BioFocus and Activiomics Announces Strategic Alliance
BioFocus expands its drug discovery offering with proteomics technology from Activiomics.
Thursday, July 26, 2012
BioFocus and InterMed Discovery Announce Marketing Collaboration
IMD will make natural product screening libraries available and provide follow-on services to BioFocus.
Wednesday, July 20, 2011
BioFocus Enters Collaboration with Michael J. Fox Foundation
Collaboration agreement for Parkinson’s Research, a not-for-profit organization focused on developing therapies for Parkinson’s disease.
Thursday, July 14, 2011
BioFocus Extends Collaboration with Usher III Initiative
BioFocus will further advance the project with the objective of delivering a pre-clinical candidate.
Wednesday, June 22, 2011
BioFocus Leads Compound Library Market with Innovative Business Model
Libraries are designed to target protein families of particular interest to the subscribers.
Friday, April 15, 2011
BioFocus and Almac Collaborate to Offer Fluorescent Lifetime Assays
FLT offers a robust, antibody free, homogeneous assay platform which enables the user to avoid interference from fluorescent compounds within a screening library.
Monday, April 11, 2011
BioFocus Extends Collaboration with Amgen into 2012
BioFocus has announced that it has extended its contract with Amgen for 2011 and 2012, with an expansion to include target discovery and validation services.
Friday, December 17, 2010
BioFocus Renews French Research Tax Credit Accreditation
The accreditation allows eligible French companies to benefit from significant tax relief on research carried out by BioFocus on their behalf until 2013.
Wednesday, June 09, 2010
BioFocus to Host Free Webinar on “Unleashing the Power of Computational Chemistry in Hit Finding Campaigns”
Attendees will learn how computational chemistry tools enable cost- and time-efficient HTS campaigns.
Friday, May 07, 2010
BioFocus Launches Four Compound Libraries Targeting Kinases and Protein-protein Interactions
BioFocus, a leading provider of gene-to-clinical candidate drug discovery services, has announced the launch of four biologically targeted libraries. These new libraries contain novel, drug-like compounds that specifically target kinases and protein-protein interactions.
Tuesday, May 04, 2010
BioFocus boosts Ion Channel Screening Capability
BioFocus has appointed Dr Iain James as Director of Biology and has commissioned an IonWorks Quattro™ high-throughput electrophysiology screening system.
Monday, September 12, 2005
BioFocus collaboration with Mitsubishi

Monday, February 24, 2003
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos